(Q36168476)

12 August 2017

1 reference

title

Potential of proteomics towards the investigation of the IGF-independent actions of IGFBP-3. (English)

1 reference

12 August 2017

author name string

Sherryline Jogie-Brahim

series ordinal

1

1 reference

12 August 2017

Hae-Ki Min

series ordinal

2

1 reference

12 August 2017

Youngman Oh

series ordinal

3

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Expert Review of Proteomics

12 August 2017

published in

1 reference

12 August 2017

volume

2

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

71-86

1 reference

Making a rational diagnosis of growth-hormone deficiency

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Type-2 IGF receptor: a multi-ligand binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Bovine lactoferrin binds to insulin-like growth factor-binding protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

The endocytic pathway: a mosaic of domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Lipid rafts and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Signaling from the far side

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Signal transduction by the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Regulated portals of entry into the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Distinct endocytic pathways regulate TGF-β receptor signalling and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Current developments in SELDI affinity technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Phosphorylation of insulin-like growth factor binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Identification of the major sites of phosphorylation in IGF binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Expression of IGF-binding protein-1 phosphoisoforms in fasted rat skin and its role in regulation of collagen biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Improved detection of hydrophilic phosphopeptides using graphite powder microcolumns and mass spectrometry: evidence for in vivo doubly phosphorylated dynamin I and dynamin III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

An approach to locate phosphorylation sites in a phosphoprotein: mass mapping by combining specific enzymatic degradation with matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Identification of phosphorylation sites in proteins separated by polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Mass spectrometry and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.1.71

21 January 2018

Identifiers

DOI

10.1586/14789450.2.1.71

1 reference

12 August 2017

1 reference